Sorry, you need to enable JavaScript to visit this website.

FAQs | DARZALEX® IV (daratumumab)

Frequently asked questions about DARZALEX®

Here are some of the more frequently asked questions about DARZALEX®. Click on the question to reveal the answer.

DARZALEX® is a prescription medicine that is used as part of a treatment plan for patients with multiple myeloma. You may receive DARZALEX® in combination with other multiple myeloma treatments, or alone, depending on the type and number or prior treatments you’ve received, or if you are newly diagnosed and are ineligible for an autologous stem cell transplant. Read more

DARZALEX® was studied as combination therapy with other medicines and as monotherapy (by itself). You can find information about each of the studies on this site. Read more

DARZALEX® is an intravenous (IV) infusion, given through a needle placed in a vein by a healthcare professional. It may be given alone or with other medicines to treat your multiple myeloma. Your healthcare professional will determine your dose based on your weight, the time between doses, and on which DARZALEX® regimen you receive. Read more

You’ll be given a physical. You will be given medicines to help reduce the risk of infusion reactions. A healthcare professional will monitor you during your infusion. Read more

The most common side effects of DARZALEX® include cold-like symptoms (upper respiratory infection); diarrhea; constipation; decreased red blood cells; nerve damage causing tingling, numbness, or pain; tiredness; swollen hands, ankles, or feet; nausea; cough; fever; shortness of breath; feeling weak. About half the people treated with DARZALEX® experience an infusion reaction, most likely during the first infusion and less likely with future infusions. Symptoms include shortness of breath or trouble breathing, dizziness or lightheadedness (hypotension), cough, wheezing, throat tightness, runny or stuffy nose, headache, itching, nausea, vomiting, chills, and fever. Read more

Once you and your doctor have decided that DARZALEX® is right for you, Janssen CarePath will help you find the resources you may need to get started and stay on track. Janssen CarePath will give you information on insurance coverage and treatment support, and identify options that may help make your treatment more affordable. Read more

Janssen CarePath can identify cost support options that may help with managing your out-of-pocket costs—whether you have commercial or private health insurance, government coverage such as Medicare or Medicaid, or have no insurance coverage. Read more